Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
We describe a novel therapeutic approach for cirrhosis using mesenchymal stem cells (MSCs) and colony-stimulating factor-1-induced bone marrow-derived macrophages (id-BMMs) and analyze the mechanisms underlying fibrosis improvement and regeneration. Mouse MSCs and id-BMMs were cultured from mouse bone marrow and their interactions analyzed in vitro. MSCs, id-BMMs, and a combination therapy using MSCs and id-BMMs were administered to mice with CCl4-induced cirrhosis. Fibrosis regression, liver regeneration, and liver-migrating host cells were evaluated. Administered cell behavior was also tracked by intravital imaging. In coculture, MSCs induced switching of id-BMMs toward the M2 phenotype with high phagocytic activity. In vivo, the combination therapy reduced liver fibrosis (associated with increased matrix metalloproteinases expression), increased hepatocyte proliferation (associated with increased hepatocyte growth factor, vascular endothelial growth factor, and oncostatin M in the liver), and reduced blood levels of liver enzymes, more effectively than MSCs or id-BMMs monotherapy. Intravital imaging showed that after combination cell administration, a large number of id-BMMs, which phagocytosed hepatocyte debris and were retained in the liver for more than 7 days, along with a few MSCs, the majority of which were trapped in the lung, migrated to the fibrotic area in the liver. Host macrophages and neutrophils infiltrated after combination therapy and contributed to liver fibrosis regression and promoted regeneration along with administered cells. Indirect effector MSCs and direct effector id-BMMs synergistically improved cirrhosis along with host cells in mice. These studies pave the way for new treatments for cirrhosis. Stem Cells Translational Medicine 2019;8:271&284
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Analysis of mRNA expression changes for factors related to fibrosis and proregenerative factors at 1, 3, and 7 days after cell administration in the liver, and analysis of the proliferating hepatocytes. (A): mRNA expression changes of factors related to fibrosis (matrix metalloproteinases [MMP] and tissue inhibitor of metalloprotease [TIMP]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of MMP‐8 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), MMP‐9 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and MMP‐13 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100) are upregulated, whereas in 50/50 group, mRNA levels of TIMP‐1 (p < .001; day 3, compared with control, p = .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and TIMP‐3 (p < .001; day 3, compared with control, p = .038; day 3, compared with MSC100, p = .029; day 3, compared with id‐BMM100) are downregulated. (B): mRNA expression changes of proregenerative factors (hepatocyte growth factor [HGF], vascular endothelial growth factor [VEGF], and oncostatin M [OSM]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of HGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .003; day 7, compared with id‐BMM100), VEGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p < .001; day 7, compared with id‐BMM100), and OSM (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .012; day 7, compared with id‐BMM100), are upregulated. (C): Analysis of the proliferating hepatocytes by PCNA staining at day 7 after cell administration. Data are presented as the means ± SD, n = 12 in each experiment, p = .003 (day 7) compared with day 1, p = .001 (day 7) compared with day 3. Scale bar: 100 μm.](https://figures.cochat.ai/paper-figures/65e06a554da7497e9526b5c665b093a6/mesenchymal-stem-cells-and-induced-bone-marrow-derived-macrophages-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Restorative (or pro-resolving) macrophages contribute to extracellular matrix degradation, myofibroblast inactivation, and tissue remodeling.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They secrete growth factors such as insulin-like growth factor-I (IGF-I) and hepatocyte growth factor (HGF), which support tissue repair and regeneration (1–4).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, intravital imaging with two-photon excitation microscopy, which is capable of distinguishing administered fluorescently labeled cells from dead cells, revealed a higher frequency of BMDM migration into the fibrotic liver, an augmented M2 cell subset, and increased phagocytic activity in the combined therapy group cohort compared to the BMDM monotherapy group.”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [85]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While many cell therapies, including MSC therapy, face a significant challenge of poor engraftment in the liver, EPCs and macrophages show much better engraftment outcomes [78, 85].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [85]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous preclinical studies have shown that macrophage therapy can reduce carbon tetrachloride–induced liver fibrosis (47–50) or promote the repair of acute liver injury repair (44, 51).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [49]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Stutchfield, B. M., Antoine, D. J., Mackinnon, A. C., Gow, D. J., Bain, C. C., Hawley, C. A., Hughes, M. J., Francis, B., Wojtacha, D., Man, T. Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.053 · Cited by 178
Self-citationRetractedMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citationStem Cell Therapies in Clinical Trials: Progress and Challenges
Trounson, A., & McDonald, C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.007 · Cited by 1,468
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.008 · Cited by 1,381
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0395 · Cited by 850
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Curry, M. P., O’Leary, J. G., Bzowej, N., Muir, A. J., Korenblat, K. M., Fenkel, J. M., Reddy, K. R., Lawitz, E., Flamm, S. L., Schiano, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512614 · Cited by 804
Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages
Kim, J., & Hematti, P. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.09.004 · Cited by 785
Boulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R. A., Seo, S. S., Spee, B., Van Rooijen, N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2667 · Cited by 747
Self-citation
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“On one hand, studies indicate their ability to differentiate into pro-fibrogenic myofibroblasts [70], on the other hand several studies demonstrated that injection of MSCs improves liver fibrosis/cirrhosis in mice and could be used as a novel therapeutic approach [71,72].”
BackgroundMacrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Liver Macrophages: Old Dogmas and New Insights
Guillot, A., & Tacke, F. (2019) · Hepatology Communications · doi:10.1002/hep4.1356 · Cited by 335
Watanabe, Y., Tsuchiya, A., & Terai, S. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0194 · Cited by 144
Self-citationCell therapy for advanced liver diseases: repair or rebuild
Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.014 · Cited by 141
Self-citationOxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow
Liu, X., Gu, Y., Kumar, S., Amin, S., Guo, Q., Wang, J., Fang, C.-L., Cao, X., & Wan, M. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.005 · Cited by 137
Tsuchiya, A., Takeuchi, S., Watanabe, T., Yoshida, T., Nojiri, S., Ogawa, M., & Terai, S. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0107-z · Cited by 112
Self-citationMesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120
Mesenchymal stem cell therapy for liver disease: full of chances and challenges
Yang, X., Meng, Y., Han, Z., Ye, F., Wei, L., & Zong, C. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00480-6 · Cited by 101
Zhao, D., Liu, C., Zuo, K., Su, P., Li, L.-B., Xiao, G., & Cheng, L. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127362 · Cited by 113
Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization
Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Agha, D. M., Fahmi, H., Lewalle, P., Fayyad‐Kazan, M., & Merimi, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716853 · Cited by 102
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
“Combined administration of macrophages and BM-MSCs induce the infiltration of host neutrophils into the liver fibrotic area, which contribute to liver fibrosis resolution and promote regeneration (58).”
BackgroundCollagen crosslinking: effect on structure, mechanics and fibrosis progression
Kong, W., Lyu, C., Liao, H., & Du, Y. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac2b79 · Cited by 82
Watanabe, T., Tsuchiya, A., Takeuchi, S., Nojiri, S., Yoshida, T., Ogawa, M., Itoh, M., Takamura, M., Suganami, T., Ogawa, Y., et al. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.03.012 · Cited by 84
Self-citationTakeuchi, S., Tsuchiya, A., Iwasawa, T., Nojiri, S., Watanabe, T., Ogawa, M., Yoshida, T., Fujiki, K., Koui, Y., Kido, T., et al. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00132-4 · Cited by 90
Self-citationCurrent evidence on posthepatectomy liver failure: Comprehensive review
Sparrelid, E., Olthof, P. B., Dasari, B. V. M., Erdmann, J. I., Santol, J., Starlinger, P., & Gilg, S. (2022) · BJS Open · doi:10.1093/bjsopen/zrac142 · Cited by 88
Russo, V., Khatib, M. E., Prencipe, G., Citeroni, M. R., Faydaver, M., Mauro, A., Berardinelli, P., Cerveró-Varona, A., Haidar-Montes, A. A., Turriani, M., et al. (2022) · Cells · doi:10.3390/cells11030434 · Cited by 89
Fishbein, A., Wang, W., Yang, H., Yang, J., Hallisey, V. M., Deng, J., Verheul, S. M. L., Hwang, S. H., Gartung, A., Wang, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007412117 · Cited by 82
Tsuchiya, A., Takeuchi, S., Iwasawa, T., Kumagai, M., Sato, T., Motegi, S., Ishii, Y., Koseki, Y., Tomiyoshi, K., Natsui, K., et al. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00121-y · Cited by 79
Self-citationFeng, X., Feng, B., Zhou, J., Yang, J., Pan, Q., Yu, J., Shang, D., Li, L., & Cao, H. (2025) · Hepatology · doi:10.1097/hep.0000000000000831 · Cited by 60
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71
de Miguel, M. P., Prieto, I., Moratilla, A., Arias, J., & Aller, M. A. (2019) · Stem Cells International · doi:10.1155/2019/3945672 · Cited by 66
Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
Pouyanfard, S., Meshgin, N., Cruz, L. S., Diggle, K., Hashemi, H., Pham, T. V., Fierro, M., Tamayo, P., Fanjul, A., Kisseleva, T., et al. (2021) · Stem Cells · doi:10.1002/stem.3449 · Cited by 59
Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects
Karn, V., Ahmed, S., Tsai, L.-W., Dubey, R., Ojha, S. K., Singh, H. N., Kumar, M., Gupta, P. K., Sadhu, S., Jha, N. K., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101373 · Cited by 62
Liu, Y., Zeng, R., Wang, Y., Huang, W., Hu, B., Zhu, G., Zhang, R., Li, F., Han, J., & Li, Y. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146422 · Cited by 60
Peng, Y., Qing, X., Shu, H., Tian, S., Yang, W., Chen, S., Lin, H., Lv, X., Zhao, L., Chen, X., et al. (2021) · PubMed Central · doi:10.12336/biomatertransl.2021.02.003 · Cited by 56
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
Zhao, P., Sun, T., Lyu, C., Liang, K., & Du, Y. (2023) · Cell Regeneration · doi:10.1186/s13619-023-00172-9 · Cited by 48
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Basiri, A., Mansouri, F., Azari, A., Ranjbarvan, P., Zarein, F., Heidari, A., & Golchin, A. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10110-w · Cited by 48
A BMP-2–triggered in vivo osteo-organoid for cell therapy
Dai, K., Zhang, Q., Deng, S., Yu, Y., Zhu, F., Zhang, S., Pan, Y., Long, D., Wang, J., & Liu, C. (2023) · Science Advances · doi:10.1126/sciadv.add1541 · Cited by 48
Zhao, X., Amevor, F. K., Xue, X., Wang, C., Cui, Z., Dai, S., Peng, C. Y., & Li, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01876-5 · Cited by 48
Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
Liu, P., Qian, Y., Liu, X., Zhu, X., Zhang, X., Lv, Y., & Xiang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096402 · Cited by 37
Li, Y., Chen, Y.-H., Liu, B., Nie, Q., Li, L., Duan, X., Wu, L., & Chen, G. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202453 · Cited by 46
He, C., Yang, Y., Zheng, K., Chen, Y., Liu, S., Li, Y., Han, Q., Zhao, R. C., Wang, L., & Zhang, F. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622321993442 · Cited by 44
Zhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., Zhao, X., Xiao, Z., Kuang, Y., Xu, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03030-8 · Cited by 43
Kojima, Y., Tsuchiya, A., Ogawa, M., Nojiri, S., Takeuchi, S., Watanabe, T., Nakajima, K., Hara, Y., Yamashita, J., Kikuta, J., et al. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.08.005 · Cited by 43
“In a liver cirrhosis model, they disappeared from the liver, lung, and spleen after 7 d [8].”
BackgroundSelf-citationKhadrawy, S. M., Mohamed, H. M., & Mahmoud, A. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-10637-y · Cited by 39
Ito, T., Sumita, Y., Yoshida, T., Honma, R., Iwatake, M., Raudales, J. L. M., Shizuno, T., Kuroshima, S., Masuda, H., Seki, M., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1414-7 · Cited by 37
Yang, Z., Xia, Q., Lü, D., Yue, H., Zhang, J., Li, Y., Zhang, B., Li, X., & Cao, M. (2020) · Aging · doi:10.18632/aging.103962 · Cited by 35
Exosomes contribution in COVID-19 patients’ treatment
Mazini, L., Rochette, L., & Malka, G. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02884-5 · Cited by 34
Tsuchiya, A., Terai, S., Horiguchi, I., Homma, Y., Saito, A., Nakamura, N., Sato, Y., Ochiya, T., & Kino‐oka, M. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.05.003 · Cited by 34
Self-citationSynthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
Nojiri, S., Tsuchiya, A., Natsui, K., Takeuchi, S., Watanabe, T., Kojima, Y., Watanabe, Y., Kamimura, H., Ogawa, M., Motegi, S., et al. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00177-4 · Cited by 31
Self-citationGong, Q., Jiang, Y., Pan, X., & You, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16707 · Cited by 31
Shi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv2106 · Cited by 30
Exosomes targeted towards applications in regenerative medicine
Xie, M., Wu, D., Li, G., Yang, J., & Zhang, Y. S. (2021) · Nano Select · doi:10.1002/nano.202000251 · Cited by 28
Modulation of the Activity of Stem and Progenitor Cells by Immune Cells
Alshoubaki, Y. K., Nayer, B., Das, S., & Martino, M. M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab022 · Cited by 26
Du, J., Jiang, Y. J., Liu, X., Ji, X., Xu, B., Zhang, Y., Liu, Y., Zhang, T., & Lin, J. (2022) · Stem Cells · doi:10.1093/stmcls/sxac091 · Cited by 26
Liu, P., An, Y., Zhu, T., Tang, S., Huang, X., Li, S., Fu, F., Ji, C., & Xuan, K. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1131218 · Cited by 26
Antler stem cells as a novel stem cell source for reducing liver fibrosis
Rong, X., Yang, Y., Zhang, G., Zhang, H., Li, C., & Wang, Y. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03081-z · Cited by 26
Ikarashi, S., Tsuchiya, A., Kawata, Y., Kojima, Y., Watanabe, T., Takeuchi, S., Igarashi, K., Ideta-Otsuka, M., Oki, K., Takamura, M., et al. (2019) · BioResearch open access · doi:10.1089/biores.2019.0022 · Cited by 26
Self-citationMesenchymal stem cells-based therapy in liver diseases
Han, H., Jin, W., & Li, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00088-x · Cited by 25
Shiha, G. E.-S., Nabil, A., Lotfy, A., Soliman, R., Hassan, A., Ali, I. S., Gad, D. F., & Zahran, F. M. (2020) · Stem Cells International · doi:10.1155/2020/6574010 · Cited by 25
Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis
Zhao, P., Sun, T., Lyu, C., Liang, K., Niu, Y., Zhang, Y., Cao, C., Xiang, C., & Du, Y. (2022) · Advanced Science · doi:10.1002/advs.202203315 · Cited by 24
Korkida, F., Stamatopoulou, A., & Roubelakis, M. G. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad082 · Cited by 24
Mesenchymal stem cells rejuvenate cardiac muscle through regulating macrophage polarization
Zhang, B., Zhao, N., Zhang, J., Liu, Y., Zhu, D., & Kong, Y. (2019) · Aging · doi:10.18632/aging.102009 · Cited by 23
Inflammatory Network of Liver Fibrosis and How It Can Be Targeted Therapeutically
Lowe, K., Tanase, C. E., Maghami, S., Fisher, L. E., & Ghaemmaghami, A. M. (2023) · Immuno · doi:10.3390/immuno3040023 · Cited by 22
Sequential drug delivery for liver diseases
Huang, X., Lee, F., Teng, Y., Lingam, C. B., Chen, Z., Sun, M., Song, Z., Balachander, G. M., Leo, H. L., Guo, Q., et al. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.001 · Cited by 19
Zheng, Y., Li, L., Bi, X., & Xue, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2818433 · Cited by 19
Hirakawa, T., Yotsumoto, F., Shirasu, N., Kiyoshima, C., Urushiyama, D., Yoshikawa, K., Miyata, K., Kurakazu, M., Koga, K., Aoki, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11891-5 · Cited by 19
Hu, Z., Chen, G., Yan, C., Li, Z., Wu, T., Li, L., & Zhang, S. (2023) · Environmental Toxicology · doi:10.1002/tox.23795 · Cited by 18
“These two types of cells can directly affect the outcome of liver injury and fibrosis.(13)”
BackgroundLiver Disease and Cell Therapy: Advances Made and Remaining Challenges
Khan, S., Mahgoub, S., Fallatah, N. A., Lalor, P. F., & Newsome, P. N. (2023) · Stem Cells · doi:10.1093/stmcls/sxad029 · Cited by 18
Efficient delivery of mesenchymal stem/stromal cells to injured liver by surface PEGylation
Takayama, Y., Kusamori, K., Katsurada, Y., Obana, S., Itakura, S., & Nishikawa, M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03446-w · Cited by 18
Therapeutic interventions of acute and chronic liver disorders: A comprehensive review
Ali, F. E. M., El‐Aziz, M. K. A., Sharab, E. I., & Bakr, A. G. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i1.19 · Cited by 18
Xu, Q., Liu, M., Meng, R., Zhao, Q., Men, X., Lan, Y., & Xu, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-48088-3 · Cited by 17
Barcena, A. J. R., Owens, T. C., Melancon, S., Workeneh, I., Cao, H. S. T., Vauthey, J., & Huang, S. Y. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10719-1 · Cited by 17
Liver regeneration as treatment target for severe alcoholic hepatitis
Virović-Jukić, L., Ljubas, D., Stojsavljević, S., Ljubičić, N., Kanižaj, T. F., Mikolašević, I., & Grgurević, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i32.4557 · Cited by 16
Liu, Z., Zhou, S., Zhang, Y., & Zhao, M. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00432-4 · Cited by 16
Stem cell therapy as a promising strategy in necrotizing enterocolitis
Di, S.-J., Wu, S.-Y., Liu, T., & Shi, Y. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00536-y · Cited by 15
Role of exosomes in viral infections: a narrative review
Marca, R. D., Giugliano, R., Zannella, C., Acunzo, M., Parimal, P., Mali, A., Chianese, A., Iovane, V., Galdiero, M., & Filippis, A. D. (2025) · Virus Research · doi:10.1016/j.virusres.2025.199644 · Cited by 15
Roles of circular RNAs in osteogenic differentiation of bone marrow mesenchymal stem cells (Review)
Wang, J., Wang, T., Zhang, F., Zhang, Y., Guo, Y., Jiang, X. P., & Yang, B. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12743 · Cited by 15
Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
Fang, Y., Lao, P., Tang, L., Chen, J., Chen, Y., Sun, L., Tan, W., & Fan, X. (2023) · Cell Transplantation · doi:10.1177/09636897231184611 · Cited by 16
Hoseinzadeh, A., Mahmoudi, M., Rafatpanah, H., Rezaieyazdi, Z., Afshari, J. T., Hosseini, S., & Esmaeili, S. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03578-z · Cited by 15
Iwasawa, T., Nojiri, S., Tsuchiya, A., Takeuchi, S., Watanabe, T., Ogawa, M., Motegi, S., Sato, T., Kumagai, M., Nakaya, T., et al. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.07.002 · Cited by 14
“Our results after injecting MSCs were consistent with those of a previous study [6].”
BackgroundResultSelf-citationImmune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells
Yi, Q., Yang, J., Wu, Y., Wang, Y., Cao, Q., & Wen, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204524 · Cited by 14
Zhang, J., Akiyama, K., Mun, A. Y., Tagashira, R., Zou, T., Matsunaga, N., Kohno, T., & Kuboki, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063252 · Cited by 14
Goudreau, A. D., Everest, C., Nagpal, T. S., Puranda, J. L., Bhattacharjee, J., Vasanthan, T., & Adamo, K. B. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13488 · Cited by 14
Yang, G., Huang, H., Tang, M., Cai, Z., Huang, C., Qi, B., & Chen, J. (2019) · Veterinary Research · doi:10.1186/s13567-019-0695-2 · Cited by 14
Tao, H., Liu, Q., Zeng, A., & Song, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110497 · Cited by 13
Definitive Endodermal Cells Supply an in vitro Source of Mesenchymal Stem/Stromal Cells
Zhang, Y., Ye, Y., Xiao, X., Hu, L., Xu, J., Zheng, D., Koc, H. C., Chan, U. I., Meng, Y., Lu, L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04810-5 · Cited by 13
Ishii, Y., Tsuchiya, A., Natsui, K., Koseki, Y., Takeda, N., Tomiyoshi, K., Yamazaki, F., Yoshida, Y., Shimbo, T., Tamai, K., et al. (2022) · Hepatology Research · doi:10.1111/hepr.13825 · Cited by 13
Self-citationNovel regulators of hepatic macrophages in liver fibrosis
Tang, X., Bai, M., Du, X., Wang, H., Liu, M., Fu, X., Zhang, H., Liang, S., & Wang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1705503 · Cited by 12
Immunomodulatory Macrophages Enable E-MNC Therapy for Radiation-Induced Salivary Gland Hypofunction
Honma, R., Takashi, I., Seki, M., Iwatake, M., Ogaeri, T., Hasegawa, K., Ohba, S., Tran, S. D., Asahina, I., & Sumita, Y. (2023) · Cells · doi:10.3390/cells12101417 · Cited by 12
Mesenchymal stem cell-based therapy for paraquat-induced lung injury
Zhang, X., Li, T., & Lu, Y. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09911-3 · Cited by 11
Takeda, N., Tsuchiya, A., Mito, M., Natsui, K., Natusi, Y., Koseki, Y., Tomiyoshi, K., Yamazaki, F., Yoshida, Y., Abé, H., et al. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00299-x · Cited by 11
Self-citationMa, Y., Bao, Y., Wang, H., Jiang, H., Zhou, L., Yang, B., Huang, X., Yang, W., Xie, D., & Zhang, J. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae016 · Cited by 11
Han, J. H., Kim, O., Lee, S. C., Kim, K., Park, J. H., Lee, J. I., Lee, K. H., Hong, H., Seo, H., Choi, H. J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246302 · Cited by 11
Li, S., Fu, X., Wang, J., Yang, H., Wang, D., Dong, X., Duan, Y., Wang, H., Yan, Y., & Si, W. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03934-7 · Cited by 10
Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases
Liu, P., Yao, L., Hu, X., Wang, Z., Xiong, Z., & Jiang, Y. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16247 · Cited by 10
Exploring the Most Promising Stem Cell Therapy in Liver Failure: A Systematic Review
Pawitan, J. A. (2019) · Stem Cells International · doi:10.1155/2019/2782548 · Cited by 10
Stem cell transplantation for treating liver diseases: progress and remaining challenges.
Li, S., Bi, Y., Duan, Z., Chang, Y.-K., Hong, F., & Chen, Y. (2021) · American Journal of Translational Research · Cited by 10
The Role of Immune Cells in Liver Regeneration
Wen, Y. (2023) · Livers · doi:10.3390/livers3030029 · Cited by 9
Platelet-rich plasma-derived extracellular vesicles improve liver cirrhosis in mice
Maeda, Y., Watanabe, Y., Ishikawa, N., Yoshida, T., Kimura, N., Abé, H., Sakamaki, A., Kamimura, H., Yokoo, T., Kamimura, K., et al. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.10.010 · Cited by 9
Self-citationKothari, A., Singh, V., Nath, U. K., Kumar, S., Rai, V., Kaushal, K., Omar, B. J., Pandey, A., & Jain, N. K. (2020) · Biology · doi:10.3390/biology9090243 · Cited by 9
Terai, S., Tsuchiya, A., Watanabe, Y., & Takeuchi, S. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00178-3 · Cited by 9
Self-citationKweon, M., Kim, J. Y., Jun, J. H., & Kim, G. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010239 · Cited by 9
Nishi, M., Matsumoto, T., Fujisawa, K., Suehiro, Y., Takami, T., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0123 · Cited by 9
Soma, G., Oda, M., Tjhin, V. T., Kohchi, C., & Inagawa, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563484 · Cited by 8
Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine
Salybekov, A. A., Hassanpour, M., Kobayashi, S., & Asahara, T. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03428-y · Cited by 8
High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice
Hokkoku, D., Sasaki, K., Kobayashi, S., Shimbo, T., Kitayama, T., Yamazaki, S., Yamamoto, Y., Ouchi, Y., Imamura, H., Kado, T., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02112-z · Cited by 8
Imamura, H., Tomimaru, Y., Kobayashi, S., Harada, A., Kita, S., Sasaki, K., Iwagami, Y., Yamada, D., Noda, T., Takahashi, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-90805-7 · Cited by 8
Wang, Y., Wang, M.-L., Tao, Y.-C., Wu, D., Chen, E., & Tang, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03455-9 · Cited by 8
Metadata
- Authors
- Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., Yamagiwa, S., Forbes, S. J., Ishii, M., & Terai, S.
- Affiliations
- Niigata University (JP)
- b Medical Research Council Centre for Regenerative Medicine The University of Edinburgh, Edinburgh, United Kingdom
- MRC Centre for Regenerative Medicine (GB)
- The University of Osaka (JP)
- Corresponding author
- Tsuchiya, Atsunori
- Terai, Shuji
- ORCID
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-05
- Volume
- 8
- Issue
- 3
- Pages
- 271-284
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- PMC
- PMC6392382
- OpenAlex
- W2900422864
- Cited by
- 155
- References
- 29
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 13 · 2023: 30 · 2022: 26 · 2021: 27 · 2020: 18 · 2019: 13
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Stem Cells Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Agency for Medical Research and Development (17fk0210101h0001, 16bm0504003h0206)
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- mesenchymal stem cells, liver fibrosis, liver cirrhosis, M2 macrophage polarization, phagocytosis, hepatocyte regeneration, matrix metalloproteinases, hepatocyte growth factor, oncostatin M, vascular endothelial growth factor, carbon tetrachloride-induced liver injury, intravital imaging, macrophage migration, neutrophil infiltration
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Liver, Liver Cirrhosis, Liver Regeneration, Macrophages, Male, Mice, Inbred C57BL, Neutrophils, Hepatocytes, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.